Deutsche Bank AG Increases Stake in Integer Holdings Co. (NYSE:ITGR)

Deutsche Bank AG grew its holdings in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 49.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 29,381 shares of the medical equipment provider's stock after purchasing an additional 9,770 shares during the quarter. Deutsche Bank AG owned approximately 0.09% of Integer worth $3,894,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Mather Group LLC. increased its holdings in Integer by 304.3% in the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock worth $25,000 after acquiring an additional 143 shares in the last quarter. Lee Danner & Bass Inc. purchased a new stake in Integer in the 4th quarter worth approximately $27,000. R Squared Ltd purchased a new stake in Integer in the 4th quarter worth approximately $44,000. Sterling Capital Management LLC increased its holdings in Integer by 472.9% in the 4th quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock worth $45,000 after acquiring an additional 279 shares in the last quarter. Finally, Principal Securities Inc. boosted its stake in Integer by 31.2% in the 4th quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider's stock worth $85,000 after purchasing an additional 152 shares during the period. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Price Performance

Shares of NYSE ITGR traded up $0.27 during midday trading on Friday, reaching $118.43. 244,616 shares of the stock traded hands, compared to its average volume of 372,916. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The stock has a market capitalization of $4.13 billion, a PE ratio of 35.25, a P/E/G ratio of 1.72 and a beta of 1.03. Integer Holdings Co. has a one year low of $104.93 and a one year high of $146.36. The company's 50 day moving average is $118.40 and its 200 day moving average is $129.13.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The company had revenue of $437.39 million during the quarter, compared to the consensus estimate of $428.51 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. Integer's revenue was up 7.3% on a year-over-year basis. During the same period last year, the company earned $1.14 earnings per share. On average, equities research analysts anticipate that Integer Holdings Co. will post 6.01 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO Joseph W. Dziedzic sold 338,975 shares of the firm's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total value of $41,751,550.75. Following the completion of the sale, the chief executive officer now directly owns 47,000 shares in the company, valued at $5,788,990. This trade represents a 87.82% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.16% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several research analysts have weighed in on ITGR shares. Raymond James upped their price target on Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday, April 25th. Truist Financial set a $150.00 price target on Integer and gave the stock a "buy" rating in a research note on Friday, April 25th. KeyCorp dropped their price target on Integer from $154.00 to $145.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Benchmark dropped their price target on Integer from $150.00 to $140.00 and set a "buy" rating for the company in a research note on Friday, April 25th. Finally, Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and increased their target price for the company from $133.00 to $140.00 in a research report on Thursday. Two analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $145.00.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.